Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Calidi Biotherapeutics (CLDI) Exercises $2.1M of Warrants
-
Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
-
Ladenburg Thalmann Reiterates Buy Rating on Palisade Bio Inc. (PALI)
-
Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises
-
BiomX (PHGE) PT Lowered to $2 at Ladenburg Thalmann
-
NeuroMetrix Reports Q1 2024 Business Highlights
-
Ladenburg Thalmann & Co. Inc. Elevates Executive Leadership with Co-CEO Appointments
-
Capricor Therapeutics (CAPR) PT Raised to $25 at Ladenburg Thalmann
-
Form 13F-NT LADENBURG THALMANN ASSET For: Mar 31
-
SoundHound AI (SOUN) stock jumps on strong subscription demand in Q1
-
Ladenburg Thalmann Downgrades Ready Capital Corp. (RC) to Neutral
-
Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
-
Saratoga Investment Corp. Announces Fiscal Year-End and Fourth Quarter 2024 Financial Results
-
Osaic Completes Acquisition of Lincoln Wealth
-
Palisade Bio Inc. (PALI) Announces $4 Million Private Placement of Common Stock, Warrants
-
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
-
TG Therapeutics (TGTX) PT Raised to $40 at Ladenburg Thalmann
-
Ladenburg Thalmann Starts Marker Therapeutics (MRKR) at Buy
-
Alliant Energy (LNT) PT Lowered to $48 at Ladenburg Thalmann
-
Biodexa Pharmaceuticals (BDRX) Enters Exclusive License to eRapa
-
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
-
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
-
Ladenburg Thalmann Starts Spire (SR) at Neutral
-
Gryphon Digital Mining (GRYP) Enters $70M ATM Agreement
-
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
-
NeuroMetrix (NURO) Announces Steps Taken to Enhance Shareholder Value
-
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
-
Aileron Therapeutics Inc (ALRN) PT Raised to $19 at Ladenburg Thalmann
-
Calidi Biotherapeutics (CLDI) Announces Pricing of $6.1 Million Public Offering
-
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
-
Instant View: March US CPI surprise may stay Fed's hand on June cut
-
SoundHound AI (SOUN) enters Equity Distribution Agreement
-
Great Elm Capital Corp. Prices Public Offering of $30,000,000 of 8.50% Notes Due 2029
-
Great Elm Capital Corp. Announces Public Offering of Unsecured Notes
-
Byrna Technologies Inc. (BYRN) PT Raised to $16.25 at Ladenburg Thalmann
-
Ladenburg Thalmann Upgrades Forte Biosciences Inc. (FBRX) to Buy
-
Acrivon Therapeutics Inc (ACRV) PT Lowered to $14 at Ladenburg Thalmann
-
Ladenburg Thalmann Downgrades Energous Corp (WATT) to Neutral, 'confidence has waned'
-
Ladenburg Thalmann Starts Evergy (EVRG) at Neutral
-
Ladenburg Thalmann Starts Inuvo (INUV) at Buy, 'Delivering AI Solutions for the Digital Ad Space in a Post-Cookie World'
-
Eagle Point Income Company (EIC) Prices Offering of Preferred Stock
-
Eagle Point Income Company Inc. Prices Offering of Preferred Stock
-
Eagle Point Income Company (EIC) Announces Preferred Share Offering
-
Eagle Point Income Company Inc. Announces Offering of Preferred Stock
-
Ladenburg Thalmann Reiterates Buy Rating on SoundHound AI Inc. (SOUN)
-
Osaic Welcomes Kings Mill Wealth Advisors
-
Ladenburg Thalmann Downgrades Spruce Biosciences, Inc. (SPRB) to Neutral, 'Regulatory Path Unclear'
-
Osaic Welcomes Cohen Financial Services from Cetera Advisors
-
Monroe Capital (MRCC) PT Lowered to $9 at Ladenburg Thalmann
-
Intelligent Bio Solutions (INBS) Announces Closing of $10.1 Million Private Placement

